ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding ImageneBio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 57 | 53 | −4 |
| Shares | 28.4M | 31.7M | +3.30M (+11.6%) |
| Value | $49.1M | $52.0M | +$2.86M (+5.8%) |
New holders (7)
Institutions that held ImageneBio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gilead Sciences, Inc. | 2,008,338 | $3.29M | 0.21% |
| Peapod Lane Capital LLC | 507,868 | $832.9K | 0.83% |
| BNP Paribas Arbitrage, SA | 44,040 | $72.2K | 0.00% |
| Squarepoint Ops LLC | 43,640 | $71.6K | 0.00% |
| Engineers Gate Manager LP | 18,934 | $31.1K | 0.00% |
| XTX Topco Ltd | 12,528 | $20.5K | 0.00% |
| SBI Securities Co., Ltd. | 3 | $5 | 0.00% |
Sold out (11)
Institutions that held ImageneBio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Acuitas Investments, LLC | 449,656 | $777.9K |
| FNY Investment Advisers, LLC | 231,383 | $400.0K |
| Susquehanna International Group, LLP | 57,090 | $98.8K |
| Prelude Capital Management, LLC | 50,638 | $87.6K |
| ADAR1 Capital Management, LLC | 44,635 | $77.2K |
| Jane Street Group, LLC | 37,270 | $64.5K |
| Corsair Capital Management, L.P. | 24,830 | $43.0K |
| Qube Research & Technologies Ltd | 17,352 | $30.0K |
| LPL Financial LLC | 12,000 | $20.8K |
| Catalyst Funds Management Pty Ltd | 4,500 | $7.79K |
| Russell Investments Group, Ltd. | 2,728 | $4.72K |